Idt Australia Ltd has released a press release.
Completion of private placement
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from IDT Australia
- CMAX - Opening of new Clinical Trial Facility
- FDA Approval for Temozolomide
- Reinstatement to Official Quotation
- Manufacturing partner appointed
- Thiotepa - Contract Extension and Revenues
Later from IDT Australia
- Awarded Future Industries Manufacturing Program Grant
- Cancellation of shares
- Trading halt
- IDT Divests CMAX Clinical Trial Business to Irom Group
- IDT: 1st generic proprietary prod shipped to US, temozolomide
Follow IDT Australia into a list and get an email when it puts out news.
Follow IDT Australia